Spectral Medical Overview
Spectral Medical (EDTXF) has a ROE of 51.04%, above the sector sector average of 11.75%.
Get informed when a big investor buys or sells
+ Follow51.04%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Spectral Medical (EDTXF) currently reports a ROE of 51.04%. That is above the sector sector average of 11.75%. Use the charts on this page to explore Spectral Medical's ROE history and peer comparisons.
Spectral Medical's ROE of 51.04% is higher than the its sector sector average of 11.75%. That is roughly 334.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Spectral Medical's current 51.04% should be judged against industry norms (sector average: 11.75%) and against EDTXF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 51.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for Spectral Medical, and consider following EDTXF for alerts when major investors trade the stock.
